{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:46:03Z","timestamp":1778867163543,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CONACyT","award":["SALUD-2012-01-182277"],"award-info":[{"award-number":["SALUD-2012-01-182277"]}]},{"name":"CONACyT","award":["SALUD-17-01-289930-01-008"],"award-info":[{"award-number":["SALUD-17-01-289930-01-008"]}]},{"name":"Fondos Federales 2012"},{"name":"Recursos Fiscales Para Investigaci\u00f3n 2017","award":["2017"],"award-info":[{"award-number":["2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Pigmentary mosaicism constitutes a heterogeneous group of skin pigmentation alterations associated with multisystem involvement. The aim of this study was to establish a complete cytogenetic and molecular characterization of PM patients, emphasizing on searching for possible low chromosomal mosaicism and on establishing an accurate genotype-phenotype correlation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 73 patients were included (3\u2009months to 18\u2009years of age), 52% male and 48% female. Observed in 69 (95%) patients, the most frequent pattern of pigmentation was fine and whorled BL, which was associated with disseminated skin extent in 41 (59%) patients. Central nervous system (84%) alterations were the most frequent observed in the group of patients, followed by the musculoskeletal (53%) and ophthalmologic (27%) alterations. Considering the pattern of pigmentation, no significant differences in association with skin extent or extracutaneous manifestations were detected. Following a strict cytogenetic analysis strategy, screening metaphases from three different tissues (peripheral blood, hyperpigmented and hypopigmented skin) we found that 23\/73 patients had chromosomal abnormalities classified as follows: 1) Mosaic with 2 or more different cell lines with structural alterations <jats:italic>n<\/jats:italic>\u00a0=\u200919; 2) Polyploidy (mosaic) <jats:italic>n<\/jats:italic>\u00a0=\u20091 and 3) Alterations in all cells in three different tissues <jats:italic>n<\/jats:italic>\u00a0=\u20093. SNP array, array CGH and FISH were useful for the complete characterization of the chromosomal aberrations, for the detection of microdeletions in patients with normal karyotype but with strong clinical suspicious of chromosomal alteration, and for a better establishment of genotype-phenotype correlation. In 2 patients we found genes associated with some of the extracutaneous manifestations (<jats:italic>SHH, MNX1, PPP2R2C<\/jats:italic>).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This group of 73 patients finely described is the largest series of patients with pigmentary mosaicism reported worldwide. As we showed in this study, the followed analysis strategy allowed the detection of cytogenetic and molecular abnormalities, and made possible the establishment of genotype-phenotype associations in some patients. An important limitation of our study was the analysis of fibroblasts cultures instead of melanocytes and keratinocytes. In some cases the direct molecular DNA analysis of skin biopsy could be another choice.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-019-1208-0","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T16:02:32Z","timestamp":1573833752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Genetic and clinical characterization of 73 Pigmentary Mosaicism patients: revealing the genetic basis of clinical manifestations"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3301-7357","authenticated-orcid":false,"given":"C.","family":"Salas-Labad\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"G\u00f3mez-Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cruz-Alc\u00edvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Mart\u00ednez-Anaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Del Castillo-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dur\u00e1n-McKinster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ulloa-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Yokoyama-Rebollar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruiz-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Navarrete-Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lieberman-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gonz\u00e1lez-Del Angel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cervantes-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Villarroel-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Reyes-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Su\u00e1rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pedraza-Mel\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gonz\u00e1lez-Orsuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"P\u00e9rez-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MD.0000000000002705","volume":"95","author":"V Pavone","year":"2016","unstructured":"Pavone V, Signorelli SS, Pratic\u00f2 AD, Corsello G, Savasta S, Falsaperla R, et al. Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports. Medicine (Baltimore). 2016;95:10.","journal-title":"Medicine (Baltimore)"},{"key":"1208_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clindermatol.2010.09.012","volume":"29","author":"V Molho-Pessach","year":"2011","unstructured":"Molho-Pessach V, Schaffer JV. Blaschko lines and other patterns of cutaneous mosaicism. Clin Dermatol. 2011;29:205\u201325.","journal-title":"Clin Dermatol"},{"key":"1208_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0778-6","volume":"13","author":"AB Kromann","year":"2018","unstructured":"Kromann AB, Ousager LB, Ali IKM, Aydemir N, Bygum A. Pigmentary mosaicism: a review of original literature and recommendations for future handling. Orphanet J Rare Dis. 2018;13:1.","journal-title":"Orphanet J Rare Dis"},{"key":"1208_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0038-1667067","volume":"16","author":"M Ruggieri","year":"2018","unstructured":"Ruggieri M, Pratic\u00f2 A, Lacarrubba F, Micali G, Schepis C, Polizzi A. Archetypical patterns of skin manifestations in Neurocutaneous disorders. J Pediatr Neurol. 2018;16:255\u201364.","journal-title":"J Pediatr Neurol"},{"key":"1208_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-38765-4","volume-title":"Mosaicism in Human Skin [Internet]","author":"R Happle","year":"2014","unstructured":"Happle R. Mosaicism in Human Skin [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 1\u20132."},{"key":"1208_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/archderm.1996.03890340027005","volume":"132","author":"KS Nehal","year":"1996","unstructured":"Nehal KS. Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko. Arch Dermatol. 1996;132:1167.","journal-title":"Arch Dermatol"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1525-1470.2007.00325.x","volume":"24","author":"Anita Pinheiro","year":"2007","unstructured":"Pinheiro A, Mathew MC, Thomas M, Jacob M, Srivastava VM, Cherian R, et al. The clinical profile of children in India with Pigmentary anomalies along the lines of Blaschko and central nervous system manifestations: Pigmentary anomalies along the lines of Blaschko and CNS manifestations. Pediatr Dermatol. 2007:11\u20137.","journal-title":"Pediatric Dermatology"},{"key":"1208_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/088307380001501001","volume":"15","author":"M Ruggieri","year":"2000","unstructured":"Ruggieri M, Pavone L. Topical review: Hypomelanosis of Ito: clinical syndrome or just phenotype? J Child Neurol. 2000;15:635\u201344.","journal-title":"J Child Neurol"},{"key":"1208_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1525-1470.1992.tb00317.x","volume":"9","author":"R Ruiz-Maldonado","year":"1992","unstructured":"Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, Castillo V. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol. 1992;9:1\u201310.","journal-title":"Pediatr Dermatol"},{"key":"1208_CR10","first-page":"10","volume":"14","author":"AY Kentab","year":"2014","unstructured":"Kentab AY. The neurologic aspects of hypomelanosis of Ito: case report and review of the literature. Sudanese J Paediatrics. 2014;14:10.","journal-title":"Sudanese J Paediatrics"},{"key":"1208_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.mop.0000171319.84053.45","volume":"17","author":"VA Lombillo","year":"2005","unstructured":"Lombillo VA, Sybert VP. Mosaicism in cutaneous pigmentation. Curr Opin Pediatr. 2005;17:494\u2013500.","journal-title":"Curr Opin Pediatr"},{"key":"1208_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1085-5629(97)80035-1","volume":"16","author":"CA Loomis","year":"1997","unstructured":"Loomis CA. Linear hypopigmentation and hyperpigmentation, including mosaicism. Semin Cutan Med Surg. 1997;16:44\u201353.","journal-title":"Semin Cutan Med Surg"},{"key":"1208_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/(SICI)1096-8628(19990806)85:4<346::AID-AJMG7>3.0.CO;2-1","volume":"85","author":"W K\u00fcster","year":"1999","unstructured":"K\u00fcster W, K\u00f6nig A. Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism. Am J Med Genet. 1999;85:346\u201350.","journal-title":"Am J Med Genet"},{"key":"1208_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/archderm.1996.03890340098016","volume":"132","author":"AS Paller","year":"1996","unstructured":"Paller AS. Pigmentary patterning as a clinical clue of genetic mosaicism. Arch Dermatol. 1996;132:1234\u20135.","journal-title":"Arch Dermatol"},{"key":"1208_CR15","first-page":"193","volume":"45","author":"IT Thomas","year":"1989","unstructured":"Thomas IT. Association of Pigmentary Anomalies with chromosomal and genetic Mosaicism and Chimerism. Am J Hum Genet. 1989;45:193\u2013205.","journal-title":"Am J Hum Genet"},{"key":"1208_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.pcl.2010.07.007","volume":"57","author":"J Treat","year":"2010","unstructured":"Treat J. Patterned pigmentation in children. Pediatr Clin N Am. 2010;57:1121\u20139.","journal-title":"Pediatr Clin N Am"},{"key":"1208_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2004.06057.x","volume":"151","author":"SM Taibjee","year":"2004","unstructured":"Taibjee SM, Bennett DC, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol. 2004;151:269\u201382.","journal-title":"Br J Dermatol"},{"key":"1208_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1440-0960.1997.tb01108.x","volume":"38","author":"P Failla","year":"1997","unstructured":"Failla P, Romano C, Schepis C. Hypomelanosis of Ito: a syndrome requiring a multisystem approach. Australas J Dermatol. 1997;38:65\u201370.","journal-title":"Australas J Dermatol"},{"key":"1208_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/(SICI)1096-8628(19990806)85:4<330::AID-AJMG3>3.0.CO;2-M","volume":"85","author":"C Moss","year":"1999","unstructured":"Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet. 1999;85:330\u20133.","journal-title":"Am J Med Genet"},{"key":"1208_CR20","first-page":"2016","volume-title":"International Standing Committee on Human Cytogenomic Nomenclature. ISCN: an international system for human cytogenomic nomenclature","author":"J McGowan-Jordan","year":"2016","unstructured":"McGowan-Jordan J, Simons A, Schmid M. International Standing Committee on Human Cytogenomic Nomenclature. ISCN: an international system for human cytogenomic nomenclature; 2016. p. 2016."},{"key":"1208_CR21","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/ajmg.a.36503","volume":"164","author":"C Salas-Labad\u00eda","year":"2014","unstructured":"Salas-Labad\u00eda C, Cervantes-Barrag\u00e1n DE, Cruz-Alc\u00edvar R, Daber RD, Conlin LK, Leonard LD, et al. Cytogenomic and phenotypic analysis in low-level monosomy 7 mosaicism with non-supernumerary ring chromosome 7. Am J Med Genet A. 2014;164:1765\u20139.","journal-title":"Am J Med Genet A"},{"key":"1208_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/hmg\/ddq003","volume":"19","author":"LK Conlin","year":"2010","unstructured":"Conlin LK, Thiel BD, Bonnemann CG, Medne L, Ernst LM, Zackai EH, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet. 2010;19:1263\u201375.","journal-title":"Hum Mol Genet"},{"key":"1208_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13039-014-0065-8","volume":"7","author":"C Salas-Labad\u00eda","year":"2014","unstructured":"Salas-Labad\u00eda C, Lieberman E, Cruz-Alc\u00edvar R, Navarrete-Meneses P, G\u00f3mez S, Cant\u00fa-Reyna C, et al. Partial and complete trisomy 14 mosaicism: clinical follow-up, cytogenetic and molecular analysis. Mol Cytogenet. 2014;7:65.","journal-title":"Mol Cytogenet"},{"key":"1208_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.12816\/0003240","volume":"13","author":"KL Sheath","year":"2013","unstructured":"Sheath KL, Mazzaschi RL, Aftimos S, Gregersen NE, George AM, Love DR. Clinical outcomes and Counselling issues regarding partial trisomy of terminal Xp in a child with developmental delay. Sultan Qaboos Univ Med J. 2013;13:311\u20137.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"1208_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejmg.2010.06.006","volume":"53","author":"L Backx","year":"2010","unstructured":"Backx L, Vermeesch J, Pijkels E, de Ravel T, Seuntjens E, Van Esch H. PPP2R2C, a gene disrupted in autosomal dominant intellectual disability. Eur J Med Genet. 2010;53:239\u201343.","journal-title":"Eur J Med Genet"},{"key":"1208_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ccr3.1114","volume":"6","author":"JP Schacht","year":"2017","unstructured":"Schacht JP, Farnworth E, Hogue J, Rohena L. Tetraploid\u2013diploid mosaicism in a patient with pigmentary anomalies of hair and skin: a new dermatologic feature. Clin Case Rep. 2017;6:103\u20138.","journal-title":"Clin Case Rep"},{"key":"1208_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/pde.12346","volume":"31","author":"J Cohen","year":"2014","unstructured":"Cohen J, Shahrokh K, Cohen B. Analysis of 36 cases of Blaschkoid dyspigmentation: reading between the lines of Blaschko. Pediatr Dermatol. 2014;31:471\u20136.","journal-title":"Pediatr Dermatol"},{"key":"1208_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1017\/S0317167100027475","volume":"15","author":"I Pascual-Castroviejo","year":"1988","unstructured":"Pascual-Castroviejo I, L\u00f3pez-Rodriguez L. Medina M de la C, Salamanca-Maesso C, Herrero CR. Hypomelanosis of Ito. Neurological complications in 34 cases. Can J Neurol Sci J Can Sci Neurol. 1988;15:124\u20139.","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"1208_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0022-3476(89)80332-4","volume":"115","author":"MT Glover","year":"1989","unstructured":"Glover MT, Brett EM, Atherton DJ. Hypomelanosis of Ito: spectrum of the disease. J Pediatr. 1989;115:75\u201380.","journal-title":"J Pediatr"},{"key":"1208_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0387-7604(97)00097-1","volume":"20","author":"I Pascual-Castroviejo","year":"1998","unstructured":"Pascual-Castroviejo I, Roche C, Martinez-Bermejo A, Arcas J, Lopez-Martin V, Tendero A, et al. Hypomelanosis of ITO. A study of 76 infantile cases. Brain and Development. 1998;20:36\u201343.","journal-title":"Brain and Development"},{"key":"1208_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/jmg.31.9.694","volume":"31","author":"CG Woods","year":"1994","unstructured":"Woods CG, Bankier A, Curry J, Sheffield LJ, Slaney SF, Smith K, et al. Asymmetry and skin pigmentary anomalies in chromosome mosaicism. J Med Genet. 1994;31:694\u2013701.","journal-title":"J Med Genet"},{"key":"1208_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/jmg.33.3.216","volume":"33","author":"E Hatchwell","year":"1996","unstructured":"Hatchwell E, Robinson D, Crolla JA, Cockwell AE. X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X;17 translocation: evidence for functional disomy of Xp. J Med Genet. 1996;33:216\u201320.","journal-title":"J Med Genet"},{"key":"1208_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1365-2230.2009.03208.x","volume":"34","author":"SM Taibjee","year":"2009","unstructured":"Taibjee SM, Hall D, Balderson D, Larkins S, Stubbs T, Moss C. Keratinocyte cytogenetics in 10 patients with pigmentary mosaicism: identification of one case of trisomy 20 mosaicism confined to keratinocytes. Clin Exp Dermatol. 2009;34:823\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"1208_CR34","doi-asserted-by":"publisher","unstructured":"Kinsler VA, Boccara O, Fraitag S, Torrelo A, Vabres P, Diociauti A. Mosaic abnormalities of the skin \u2013 review and guidelines from the European Reference Network for rare skin diseases ( ERN -Skin). Br J Dermatol. 2019. https:\/\/doi.org\/10.1111\/bjd.17924.","DOI":"10.1111\/bjd.17924"},{"key":"1208_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/pcmr.12645","volume":"31","author":"VA Kinsler","year":"2018","unstructured":"Kinsler VA, Larue L. The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation. Pigment Cell Melanoma Res. 2018;31:95\u2013109.","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1208-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1208-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1208-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:13:21Z","timestamp":1605312801000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1208-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1208-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"5 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Research Ethics committee with National Commission of Bioethics registration number \u201cCONBIOETICA-09-CEI-025-20161215\u201d of Instituto Nacional de Pediatr\u00eda. Signed informed consent form was obtained according to the recommendations of the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent form was obtained according to the recommendations of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"259"}}